vaccinesadjuvants for vaccinesgmp productionpartneringopportunities for cooperationstrategic partnershipscompanymanagement boardsupervisory boardscientific advisory boardnewsroompress releasescurevac in the mediacurevac eventscareerscore valuescareerportal we fight for human health . curevac is the first company to successfully harness messenger rna mrna for medical purposes . the principle is promising ; use natural mrna as a data carrier to instruct the human body to produce its own proteins to fight a wide range of diseases . curevac appoints pierre kemula as chief financial officer press release of october 11 2016 read more study in peer reviewed journal vaccine demonstrates decoding mode of action of mrna vaccines press release of july 14 2016 read more study publication in plos neglected tropical disease an mrna vaccine encoding rabies virus glycoprotein induces protection ... read more media report in the wall street journal on may 23 2016 ebola zika push global health leaders on disease fight ... photo felipe dana ap read more curevac raises 110 million in a private placement further investment for development of mrna products read more work curevac do you want to fight together with us for human health you will find current vacancies on our careerportal . read more mission 666 667 668 669 670 671 0 lightbox full the rna people 678 679 680 681 682 683 0 lightbox full did you know that ... 30 31 32 580 581 582 0 lightbox animation3 impressions 33 34 589 590 591 652 654 656 708 709 710 711 712 713 757 759 761 922 924 926 928 0 lightbox animation4 founderpassion 690 691 0 lightbox full milestones 742 0 lightbox animation7 curevac ag paul ehrlich stra e 15 72076 t bingen germany contact imprint disclaimer